Latest Breaking News On - Steven gannon - Page 3 : comparemela.com

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Earnings Results, Beats Estimates By $0 07 EPS

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Earnings Results, Beats Estimates By $0 07 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sherrington robinSteven gannonSecurities exchange commissionNews ratings for xenon pharmaceuticals dailyXenon pharmaceuticals stock downCantor fitzgeraldXenon pharmaceuticalsXenon pharmaceuticals incNeedham companyRoyal bankEarnings history for xenon pharmaceuticalsInsider transactions at xenon pharmaceuticalsGet free reportPharmaceuticals stock downDirector steven gannonExchange commission

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60 00

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60 00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Sherrington robinSteven gannonAnalyst recommendations for xenon pharmaceuticalsXenon pharmaceuticalsSecurities exchange commissionXenon pharmaceuticals incXenon pharmaceuticals company profileLord abbettCantor fitzgeraldRoyal bankNeedham companyWestfield capital management coProshare advisorsXenon pharmaceuticals price performanceNews ratings for xenon pharmaceuticals dailyGet free report

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60 00

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandSteven gannonSherrington robinCantor fitzgeraldRoyal bankWellington management groupHedge funds weigh in on xenon pharmaceuticalsXenon pharmaceuticals price performanceAnalyst recommendations for xenon pharmaceuticalsAvoro capital advisorsXenon pharmaceuticals incNeedham companyCapital international investorsNews ratings for xenon pharmaceuticals dailySecurities exchange commission

Xenon Pharmaceuticals (XENE) Scheduled to Post Earnings on Thursday

Xenon Pharmaceuticals (XENE) Scheduled to Post Earnings on Thursday
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Sherrington robinSteven gannonEarnings history for xenon pharmaceuticalsXenon pharmaceuticalsInsider transactions at xenon pharmaceuticalsNeedham companyRoyal bankXenon pharmaceuticals incXenon pharmaceuticals stock downNews ratings for xenon pharmaceuticals dailyCantor fitzgeraldSecurities exchange commissionGet free reportPharmaceuticals stock downDirector steven gannonExchange commission

Xenon Pharmaceuticals Inc (NASDAQ:XENE) Receives $59 44 Average PT from Analysts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued ratings on the stock in […]

United statesNew zealand generalNew zealandSherrington robinSteven gannonNeedham companyXenon pharmaceuticalsXenon pharmaceuticals stockTimessquare capital managementInstitutional investors weigh in on xenon pharmaceuticalsNews ratings for xenon pharmaceuticals dailyXenon pharmaceuticals incRoyal bankXenon pharmaceuticals company profileBarclays plcAnalyst recommendations for xenon pharmaceuticals